[Molecular biology aspects of the antimicrobial effect of synthetic chemotherapeutic agents].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D001711:Biotransformation; D003692:Delayed-Action Preparations; D004338:Drug Combinations / Q000627:therapeutic use; D005492:Folic Acid / Q000096:biosynthesis; D006801:Humans; D008333:Mandelic Acids / Q000627:therapeutic use; D008709:Methenamine / Q000627:therapeutic use; D008967:Molecular Biology; D009268:Nalidixic Acid / Q000627:therapeutic use; D009581:Nitrofurans / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D013416:Sulfamerazine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy; D000096926:Benzenesulfonamides
D000900:Anti-Bacterial Agents; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005492:Folic Acid; D008333:Mandelic Acids; D008709:Methenamine; D009268:Nalidixic Acid; D009581:Nitrofurans; D013416:Sulfamerazine; D013449:Sulfonamides; D014295:Trimethoprim; C010413:mandelamide; C014230:trimerazine; D000096926:Benzenesulfonamides
Molekularbiologische Aspekte der antimikrobiellen Wirkung von synthetischen Chemotherapeutika.